300 related articles for article (PubMed ID: 29920485)
1. An Update on Cellular MicroRNA Expression in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma.
Emmett S; Whiteman DC; Panizza BJ; Antonsson A
Oncology; 2018; 95(4):193-201. PubMed ID: 29920485
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
3. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
4. Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.
Matsumoto F; Fujimaki M; Ohba S; Kojima M; Yokoyama J; Ikeda K
Head Neck; 2015 Jul; 37(7):977-81. PubMed ID: 24700733
[TBL] [Abstract][Full Text] [Related]
5. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.
Wemmert S; Linxweiler M; Lerner C; Bochen F; Kulas P; Linxweiler J; Smola S; Urbschat S; Wagenpfeil S; Schick B
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1129-1141. PubMed ID: 29560516
[TBL] [Abstract][Full Text] [Related]
6. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
[TBL] [Abstract][Full Text] [Related]
7. Molecular Patterns and Biology of HPV-Associated HNSCC.
Brakenhoff RH; Wagner S; Klussmann JP
Recent Results Cancer Res; 2017; 206():37-56. PubMed ID: 27699528
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
[TBL] [Abstract][Full Text] [Related]
9. HPV-Related Head and Neck Squamous Cell Carcinomas.
Marszałek A; Szylberg Ł
Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531
[TBL] [Abstract][Full Text] [Related]
10. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
[TBL] [Abstract][Full Text] [Related]
11. [HPV-associated head and neck cancer: update and recommendations for practice].
Švajdler M; Laco J; Ondič O; Kašpírková J; Mezencev R; Michal M; Skálová A
Cesk Patol; 2016; 52(3):130-8. PubMed ID: 27526013
[TBL] [Abstract][Full Text] [Related]
12. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
13. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist.
Westra WH
Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343
[TBL] [Abstract][Full Text] [Related]
14. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Božinović K; Sabol I; Dediol E; Milutin Gašperov N; Manojlović S; Vojtechova Z; Tachezy R; Grce M
Sci Rep; 2019 Feb; 9(1):2306. PubMed ID: 30783190
[TBL] [Abstract][Full Text] [Related]
16. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
17. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers.
Gillison ML; Shah KV
Curr Opin Oncol; 2001 May; 13(3):183-8. PubMed ID: 11307062
[TBL] [Abstract][Full Text] [Related]
19. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma.
Bratman SV; Bruce JP; O'Sullivan B; Pugh TJ; Xu W; Yip KW; Liu FF
JAMA Oncol; 2016 Jun; 2(6):823-6. PubMed ID: 27010835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
